Pay in 4 interest-free payments of $6.25 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
Nooms got your backand theirs
Food and Drug Administration (FDA) approved Mounjaro (tirzepatide) injection, Eli Lilly and Company's (NYSE: LLY) new once-weekly GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptor agonist indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes
Can tirzepatide help with stronger appetite control
Glucagonlike Peptide1 receptor agonists for chronic weight management
Cost and Insurance Coverage
US$ 27.88
US$ 21.32
US$ 25.19
